Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zeo ScientifiX ( (ZEOX) ) has provided an announcement.
On January 14, 2026, Zeo ScientifiX granted 175,000 restricted shares of common stock each to Chief Executive Officer and Chief Financial Officer Ian Bothwell and Chief Medical Officer Dr. George Shapiro, both of whom serve on the company’s board of directors. The awards, made under the company’s 2021 Incentive Stock Plan, are structured to vest in two equal tranches—50% eight months after the grant date and the remaining 50% one year after the grant—aligning executive compensation more closely with the company’s medium-term performance and strengthening management’s equity stake.
More about Zeo ScientifiX
Average Trading Volume: 10,957
Technical Sentiment Signal: Strong Buy
Current Market Cap: $17.69M
For detailed information about ZEOX stock, go to TipRanks’ Stock Analysis page.